Sodium Bicarbonate Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Sodium Bicarbonate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Mar 1, 2017. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-5555-02
Dosage Form
Injection
Presentation
Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)
Initial Posting
Mar 1, 2017

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.